Private company

NANOMIX Corp

NANOMIX Corp is an American pharmaceutical preparations company based in Emeryville.2

Last updated Oct 20, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersEmeryville, United States2
  • Incorporated inDE3
  • Business address354 Merrimack Street, #4, Lawrence, Ma 018433
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation2
  • LEI5493004NA3EH9FWJ2J262
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O NATIONAL REGISTERED AGENTS, INC., 19801 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 47225802

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-54609.5%Operating margin4
-79825.1%Net margin4
-89.1%Revenue growth, 20224
-$6.1MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development37¢$3.2M
  • Selling, general and admin63¢$5.3M

Out of $15.4K in revenue.4 The company lost money this year.

Financial statements

Revenue567894$15.4K in 2022−84% since 2016
0$200.0K$400.0K$600.0K2016: $98.9K$98.9K20162017: $29.4K$29.4K2017−70%2018: $31.7K$31.7K2018+8%2019: $16.3K$16.3K2019−49%2020: $513.2K$513.2K2020+3043%2021: $141.8K$141.8K2021−72%2022: $15.4K$15.4K2022−89%
Operating income567894-$8.4M in 2022+568% since 2016
-$10.0M-$7.5M-$5.0M-$2.5M02016: -$1.3M-$1.3M20162017: -$1.3M-$1.3M2017+0%2018: -$3.3M-$3.3M2018+159%2019: -$3.9M-$3.9M2019+18%2020: -$4.9M-$4.9M2020+27%2021: -$5.7M-$5.7M2021+17%2022: -$8.4M-$8.4M2022+47%
Net income56784-$12.3M in 2022+230% since 2016
-$15.0M-$10.0M-$5.0M02016: -$3.7M-$3.7M20162017: -$1.6M-$1.6M2017−58%2018: -$3.6M-$3.6M2018+127%2019: -$3.7M-$3.7M2019+3%2020: -$907.9K-$907.9K2020−75%2021: -$9.5M-$9.5M2021+943%2022: -$12.3M-$12.3M2022+30%
Fiscal year2016201720182019202020212022
Revenue$98.9K5$29.4K6$31.7K7$16.3K8$513.2K9$141.8K4$15.4K4
Cost of revenue$94.1K10
Gross profit$4.7K10
Research and development$83.8K5$177.6K6$182.7K7$1.7M8$4.2M9$3.0M4$3.2M4
Selling, general and admin$1.2M9$2.8M4$5.3M4
Operating expenses$5.9M4$8.5M4
Operating income-$1.3M5-$1.3M6-$3.3M7-$3.9M8-$4.9M9-$5.7M4-$8.4M4
Interest$21.1K7$30.3K8$08$1.5M9
Income before tax-$9.5M4-$12.3M4
Income tax$4.0K5
Net income-$3.7M5-$1.6M6-$3.6M7-$3.7M8-$907.9K8-$9.5M4-$12.3M4
Earnings per share-$1.794-$0.314
Earnings per share (diluted)-$1,440.769-$1.794-$0.314
Shares (weighted, basic)5.3M shares440.5M shares4
Shares (weighted, diluted)5.3M shares440.5M shares4

Compare NANOMIX Corp with another company

Corporate structure

NANOMIX Corp sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of NANOMIX Corp

  • Hudson Bay Capital Management LP Filed SC 13G/A on NANOMIX Corp, latest Nov 8, 2024 (4 filings since Feb 7, 2022)
  • NANOMIX Corp Emeryville, California, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What NANOMIX Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Furniture and fixtures$6.7K4 Dec 31, 2022$14.4K4 Dec 31, 2021−53.6%
Leasehold improvements$11.6K4 Dec 31, 2022$20.2K4 Dec 31, 2021−42.9%
Property and equipment, before depreciation$616.5K4 Dec 31, 2022$797.4K4 Dec 31, 2021−22.7%
Accumulated depreciation$353.5K4 Dec 31, 2022$458.1K4 Dec 31, 2021−22.8%
Property and equipment, net$263.0K4 Dec 31, 2022$339.3K4 Dec 31, 2021−22.5%
Operating-lease assets (leased space)$570.2K4 Dec 31, 2022

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$297.4K9 Dec 31, 2021$15.1K9 Dec 31, 2020+1869.5%

Leadership

Who has led NANOMIX Corp, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Kenneth A. Tassey Jr.2014
  2. Carl W. Rausch2017–2018
  3. David Ludvigson2021
  4. Thomas Schlumpberger2022

President

  1. Kenneth A. Tassey Jr.2012–2014
  2. David Ludvigson2021

Chief financial officer

  1. Anthony Don Squeglia2014–2015
  2. David Ludvigson2022
  3. Chris Hetterly2023

Chief operating officer

  1. Kenneth A. Tassey Jr.2012
  2. Jonathan B. Rome2014
  3. Loraine Upham2018
  4. Vidur Sahney2022
201520202025
Board members and other officers (14)

Former names

  • Boston Therapeutics, Inc.Mar 8, 2010 to Nov 5, 20213
  • AVANYX Therapeutics, Inc.Feb 8, 2010 to Nov 23, 20103

Timeline

  1. Nov 24, 20238-K Executive or director change35
  2. Mar 10, 20238-K Regulation FD disclosure36
  3. Jan 25, 20238-K Executive or director change37
  4. Dec 16, 2022New chief executive Thomas Schlumpberger becomes CEO14
  5. Nov 10, 20228-K Unregistered sale of shares; Other events38
  6. Sep 9, 20228-K Executive or director change39
  7. Jul 29, 20228-K Executive or director change40
  8. May 10, 20228-K Executive or director change; Other events41
  9. Mar 24, 20228-K Entered a material agreement; Unregistered sale of shares; Change to shareholders' rights42
  10. Mar 2, 20228-K Bylaws or fiscal year changed43
  11. Mar 1, 20228-K Entered a material agreement; New debt or obligation; Unregistered sale of shares44
  12. Nov 17, 20218-K Other events45
  13. Nov 5, 20218-K Other events46
  14. Jun 29, 2021New chief executive David Ludvigson becomes CEO15
  15. May 10, 2017New chief executive Carl W. Rausch becomes CEO16
  16. Apr 4, 2014New chief executive Kenneth A. Tassey Jr. becomes CEO17
  17. Aug 24, 2009Founded NANOMIX Corp is founded2

Filings

53 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 13 major events, 11 insider forms, 4 large holders, 18 other. The latest 20:

  1. Apr 9, 2025REVOKED EDGAR
  2. Nov 8, 2024SC 13G/A NNMX 13G/A EDGAR
  3. Feb 6, 2024SC 13G/A NNMX 13GA EDGAR
  4. Nov 24, 20238-K CURRENT REPORT EDGAR
  5. May 15, 2023NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  6. Apr 7, 202310-K ANNUAL REPORT EDGAR
  7. Mar 31, 2023NT 10-K NOTIFICATION OF LATE FILING EDGAR
  8. Mar 10, 20238-K EDGAR
  9. Feb 10, 2023SC 13G/A NNMX 13GA EDGAR
  10. Jan 26, 20233 EDGAR
  11. Jan 25, 20238-K CURRENT REPORT EDGAR
  12. Dec 21, 20224 OWNERSHIP DOCUMENT EDGAR
  13. Dec 21, 20223 OWNERSHIP DOCUMENT EDGAR
  14. Dec 19, 20224 EDGAR
  15. Dec 19, 20223 EDGAR
  16. Dec 19, 20223 EDGAR
  17. Dec 16, 20223 EDGAR
  18. Dec 16, 20224 OWNERSHIP DOCUMENT EDGAR
  19. Dec 16, 20223 OWNERSHIP DOCUMENT EDGAR
  20. Nov 14, 202210-Q QUARTERLY REPORT EDGAR

The 53 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

4 open-market trades by officers, directors and large owners since October 2021: 4 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Dec 9, 2022GRUENER GARRETTDirectorBuy10,000$0.25$2.5KForm 4
Aug 22, 2022GRUENER GARRETTDirectorBuy13,000$0.40$5.1KForm 4
Aug 19, 2022GRUENER GARRETTDirectorBuy2,968$0.40$1.2KForm 4
Aug 18, 2022GRUENER GARRETTDirectorBuy32$0.57$18Form 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How NANOMIX Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARNANOMIX Corp1
  • CIK0001473579
  • Employer ID (EIN)27-08010731
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address354 Merrimack Street, #4, Lawrence, MA 018431
  • Phone(603) 935-97991
  • Shares outstanding48,996,763 as of Apr 6, 20234
  • Public float$28.8M as of Jun 30, 20224
  • On EDGAR sinceFeb 8, 20101
  • Filings307 in all: 8-K (81), 10-Q (37), 4 (35), 3 (22), S-1/A (16), 10-K (13), NT 10-Q (11), 8-K/A (9)1
    All 37 form types

    EFFECT (7), NT 10-K (7), UPLOAD (7), CORRESP (6), S-1 (6), 424B3 (4), D (4), SC 13G/A (4), DEF 14C (3), POS AM (3), PRE 14C (3), S-8 (3), S-8 POS (3), SC 13D (3), 10-Q/A (2), PRER14C (2), RW (2), SC 13D/A (2), SC 13G (2), 10-K/A (1), 4/A (1), 5 (1), 8-A12G (1), AW (1), CT ORDER (1), D/A (1), NT 10-K/A (1), REVOKED (1), SC 14F1 (1)

  • Latest filingsAnnual report (10-K) Apr 7, 2023
    Quarterly report (10-Q) Nov 14, 2022
    Latest 8-K (8-K) Nov 24, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
    SEC EDGAROther events
  46. 46
    SEC EDGAROther events
  47. 47